Biotech

Brain drugs are new doping frontier

April 24th, 2007 by | No Comments

By Karen Kaplan, Denise Gellene
LOS ANGELES TIMES
Sunday, December 23, 2007
Forget sports doping. The next frontier is brain doping.
As Major League Baseball struggles to rid itself of performance-enhancing substances, people in a range of other fields are reaching for a variety of prescription pills to enhance what counts most in modern life.
Despite the potential side effects, [...]

Venture backed Domantis acquired

December 8th, 2006 by | No Comments

From Venturewire today: In one of the largest acquisitions ever of a private biotech company, GlaxoSmithKline said this morning it agreed to buy venture-backed Domantis for about $454 million in cash.
Europe’s biggest drug maker said Domantis will become part of GSK’s Biopharmaceuticals Centre of Excellence for Drug Discovery while continuing to operate from laboratories in [...]